Held · Bookmarked
1 · 0
portfolio · users
Avg position size
14.0%
of holders' portfolios
13F filers
3
institutions
Market cap
$100.3B
398M shares
52-week range
$190.12 – $370.86
39% from low
Sector
SERVICES-PREPACKAGED SOFTWARE
Exchange
NASDAQ
CS
P/S (TTM)
4.0
EV / FCF (TTM)
9.6
Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content across multiple operating systems, devices, and media. The company operates in three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).
www.adobe.com| Trader / Portfolio | Conviction |
|---|---|
| July PortfolioShkreli | Strong14% |
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 925,270 | $224.9M |
| Execution date | Ratio |
|---|---|
| 2005-05-24 | 2-for-1 |
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 55.4% | 40.5% | 32.6% | — | — | — |
| Rev. Growth % | 10.5% | 13.1% | ||||
| Profit Margin % | 30.0% | 28.3% | 28.1% | |||
| Free Cash Flow Margin % | 41.4% | 39.9% | 39.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +2.2% on the P/E track.
At today's price, your expected annual return is +7.3% on the P/E track.
At today's price, your expected annual return is +11.9% on the P/E track.
| 200,000 |
| $103.6M |
| Bridgewater Associatesas of 2026-03-31 | 1,312 | $318.9K |
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $26.6B | +12.2% | $24.48 | $24.44–$24.52 | 10.6× | 21 |
| 2027 | $29.1B | +9.3% | $27.70 | $26.39–$28.69 | 9.4× | 23 |
| 2028 | $31.6B | +8.7% | $31.53 | $28.96–$37.01 | 8.3× | 15 |
| 2029 | $34.4B | +9.0% | $34.77 | $34.09–$35.73 | 7.5× | 11 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 8 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-09-10 | $6.08 | $6.13 | +0.8% |
| 2026-06-11 | $5.82 | $5.96 | +2.4% |
| 2026-03-12 | $5.87 | $6.06 | +3.2% |
| 2025-12-10 | $5.40 | $5.50 | +1.9% |
| 2025-09-11 | $5.18 | $5.31 | +2.5% |
| 2025-06-12 | $4.97 | $5.06 | +1.8% |
| 2025-03-12 | $4.97 | $5.08 | +2.2% |
| 2024-12-11 | $4.66 |
| $4.81 |
| +3.2% |
| $354.8B |
| — |
| FTNTFortinet, Inc. | $170.18 | +9.04% | $124.9B | — |
| KLACKLA Corporation | $169.09 | -6.39% | $220.9B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
MRNA
Moderna, Inc. Common Stock
1 co-holder · 100% overlap
BCRX
BioCryst Pharmaceuticals Inc
1 co-holder · 100% overlap
STM
STMicroelectronics N.V.
1 co-holder · 100% overlap
MU
Micron Technology, Inc.
1 co-holder · 100% overlap
SNPS
Synopsys Inc
1 co-holder · 100% overlap
SPRB
Spruce Biosciences, Inc. Common Stock
1 co-holder · 100% overlap
LITE
Lumentum Holdings Inc. Common Stock
1 co-holder · 100% overlap
SRPT
Sarepta Therapeutics,, Inc. Common Stock
1 co-holder · 100% overlap
Ranked by collective conviction (sum of co-holders' % allocation) across public portfolios holding ADBE.
$ADBE Was a good run yesterday. It failed to break through the 200 days SMA. Lets hope to see Strong move to break upside after a little pull back at the resistant point. Always think positive!!!
View on StockTwits ↗
$ADBE cooked Mon on the beat/raise then faded to ~261 premarket. Lose 256.66 and that print bid's dead.
View on StockTwits ↗
$ADBE Slower frontier development moves the timeline on the AI disruption question. It does not answer it, and no model does either. Techdamentals IV Calculator 👇 https://techdamentals.com/v/ADBE Educational, not advice.
View on StockTwits ↗
$ORCL Even the anywhere but up ahh stock $ADBE has recovered more than this POS…
View on StockTwits ↗
$ORCL $CRWD $ADBE $CRM all SAAS flying….oracle the leader was down!!! Criminal
View on StockTwits ↗
Serious question. If frontier labs slowed down model releases for an entire year, which public companies could still grow operating cash flow regardless? My list: $AMZN, $MSFT, $ADBE, $META. Who else would you add that isn’t a chip vendor?
View on StockTwits ↗
$ADBE definitely heading back to test and break $300. upwards and onwards
View on StockTwits ↗
$ADBE so this has just disproven the bearish AI narrative several times over the past few years by hitting record earnings each quarter without a single miss. On top of that, the AI narrative is already cracking. As leaders are looking to slow progress of AI. There's no way this stays down. The narrative is already getting cooked
View on StockTwits ↗
$ADBE someone is going to disclose something eod based on how this is rising last few mins , buffet or insider mofos?
View on StockTwits ↗$ADBE entire board should disclose buys today including the lame duck
View on StockTwits ↗$ADBE $NOW Strong accumulation. Waiting for double digit percentage move some day this week.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.